Nicholas Maestas
Director of Finance/CFO bei TEMPEST THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Nicholas Maestas is currently the Secretary, Vice President-Finance & Strategy at Tempest Therapeutics, Inc. He previously worked as the Senior Director-Corporate Development & Operations at Immune Design Corp.
from 2014 to 2019 and as the Head-Financial Planning & Analysis at Alector, Inc. from 2019 to 2021.
Mr. Maestas completed his undergraduate degree at the University of California, Berkeley and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.01.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Nicholas Maestas
| Unternehmen | Position | Beginn |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 12.07.2021 |
Ehemalige bekannte Positionen von Nicholas Maestas
| Unternehmen | Position | Ende |
|---|---|---|
| ALECTOR, INC. | Corporate Officer/Principal | 01.07.2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01.07.2019 |
Ausbildung von Nicholas Maestas
| University of California, Berkeley | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALECTOR, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
| Tempest Therapeutics, Inc. |
